Both in Lab Analytical Instruments
Harvard Bioscience vs EyePoint
Over the past year HBIO returned +72.3% and EYPT returned −97.3%; their daily moves had a correlation of -0.01.
HBIO +72.3% EYPT −97.3%Growth of $1, one year, split-adjusted
| Metric | HBIO | EYPT |
|---|---|---|
| Price | $8.90 | $0.3484 |
| Market cap | $40.5M | $30.0M |
| Today | +1.14% | −8.32% |
| 1 month | +9.5% | −89.2% |
| 6 months | +39.9% | −97.4% |
| Year to date | +33.1% | −98.1% |
| 1 year | +99.3% | −97.0% |
| Revenue growth (YoY) | +11.1% | −90.5% |
| Gross margin | 55.6% | 100.0% |
| Net margin | −12.8% | −18633.1% |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | 10.8× |
| Net cash | -$30.2M | $180.5M |
| Dividend yield | — | — |
| Volatility (60d) | 36.4% | 453.8% |
| Short % of float | 1.5% | 25.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).